Ironwood Pharmaceuticals (IRWD) Gross Margin (2013 - 2020)

Ironwood Pharmaceuticals has disclosed Gross Margin across 7 years of filings, most recently posting 99.23% for Q4 2020.

• In Q4 2020, Gross Margin rose 795.0% year-over-year to 99.23%; the TTM figure through Dec 2020 stood at 99.19% (up 477.0% YoY), while the FY2020 annual figure was 99.19%, up 477.0% from the prior year.
• Gross Margin came in at 99.23% for Q4 2020 at Ironwood Pharmaceuticals, down from 100.0% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 100.0% in Q2 2020 to a low of 83.58% in Q4 2018.
• Average Gross Margin over 4 years is 94.97%, with a median of 95.61% recorded in 2018.
• Year-over-year, Gross Margin tumbled 689 bps in 2018 and jumped 1107 bps in 2020.
• Over 4 years, Gross Margin stood at 90.46% in 2017, then dropped by 8 bps to 83.58% in 2018, then advanced by 9 bps to 91.28% in 2019, then rose by 9 bps to 99.23% in 2020.
• Per Business Quant data, the three most recent Gross Margin figures were 99.23% in Q4 2020, 100.0% in Q3 2020, and 100.0% in Q2 2020.